Cohen K - Search Results

1

Clinician compliance with laboratory monitoring and prescribing guidelines in HIV-1-infected patients receiving tenofovir.

De Waal R, Cohen K, Fox MP, Stinson K, Maartens G, Boulle A, Davies MA. De Waal R, et al. Among authors: cohen k. S Afr Med J. 2016 Mar 9;106(4):52-3. doi: 10.7196/SAMJ.2016.v106i4.10153. S Afr Med J. 2016. PMID: 27032851

2

Antiretroviral therapy and drug interactions.

Cohen K, Andrews S, Maartens G. Cohen K, et al. S Afr Med J. 2001 Oct;91(10):816-9. S Afr Med J. 2001. PMID: 11732449 Review. No abstract available.

3

Antiretroviral therapy in a community clinic--early lessons from a pilot project.

Bekker LG, Orrell C, Reader L, Matoti K, Cohen K, Martell R, Abdullah F, Wood R. Bekker LG, et al. Among authors: cohen k. S Afr Med J. 2003 Jun;93(6):458-62. S Afr Med J. 2003. PMID: 12916388

4

Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis.

Cohen K, van Cutsem G, Boulle A, McIlleron H, Goemaere E, Smith PJ, Maartens G. Cohen K, et al. J Antimicrob Chemother. 2008 Feb;61(2):389-93. doi: 10.1093/jac/dkm484. Epub 2007 Dec 19. J Antimicrob Chemother. 2008. PMID: 18096560

5

Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.

Boulle A, Van Cutsem G, Cohen K, Hilderbrand K, Mathee S, Abrahams M, Goemaere E, Coetzee D, Maartens G. Boulle A, et al. Among authors: cohen k. JAMA. 2008 Aug 6;300(5):530-9. doi: 10.1001/jama.300.5.530. JAMA. 2008. PMID: 18677025

6

Antiretroviral therapy and early mortality in South Africa.

Boulle A, Bock P, Osler M, Cohen K, Channing L, Hilderbrand K, Mothibi E, Zweigenthal V, Slingers N, Cloete K, Abdullah F. Boulle A, et al. Among authors: cohen k. Bull World Health Organ. 2008 Sep;86(9):678-87. doi: 10.2471/blt.07.045294. Bull World Health Organ. 2008. PMID: 18797643 Free PMC article.

7

Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections.

Gounden R, Bamford C, van Zyl-Smit R, Cohen K, Maartens G. Gounden R, et al. Among authors: cohen k. BMC Infect Dis. 2009 Mar 9;9:26. doi: 10.1186/1471-2334-9-26. BMC Infect Dis. 2009. PMID: 19272139 Free PMC article.

8

Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa.

Cohen K, Grant A, Dandara C, McIlleron H, Pemba L, Fielding K, Charalombous S, Churchyard G, Smith P, Maartens G. Cohen K, et al. Antivir Ther. 2009;14(5):687-95. Antivir Ther. 2009. PMID: 19704172 Free PMC article. Clinical Trial.

9

Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries.

Maartens G, Decloedt E, Cohen K. Maartens G, et al. Among authors: cohen k. Antivir Ther. 2009;14(8):1039-43. doi: 10.3851/IMP1455. Antivir Ther. 2009. PMID: 20032533 Review.

10

Dosage adjustment in medical patients with renal impairment at Groote Schuur Hospital.

Decloedt E, Leisegang R, Blockman M, Cohen K. Decloedt E, et al. Among authors: cohen k. S Afr Med J. 2010 May 4;100(5):304-6. doi: 10.7196/samj.3955. S Afr Med J. 2010. PMID: 20460024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,001 results

Search Page

Filters